Hypothesis

Aged cells retain the ability to activate Shh signaling but lose the analog fidelity needed to convert shallow 2‑3‑fold extracellular Shh differences into proportional GLI activator/repressor ratios. We propose that age‑related ROS accumulation drives preferential HDAC recruitment to GLI3‑bound enhancers, stabilizing the repressor form and compressing the dynamic range of GLI activity. Consequently, Shh agonists elicit a uniform, high‑level response (binary on/off) rather than a graded spatial pattern.

Mechanistic Rationale

• ROS is required for basal SMO activity but, when elevated, promotes GLI3 repressor formation 2.
• GLI3 repressor function depends on HDAC‑mediated deacetylation of H3K27ac at target enhancers 6.
• In young tissues, balanced ROS levels permit transient HDAC inhibition by Shh, allowing GLI activator accumulation that mirrors the morphogen gradient 3.
• With age, chronic oxidative stress sustains HDAC activity, locking GLI3 in a repressor conformation even when SMO is engaged, thereby flattening the intracellular GLI activity gradient.

Testable Predictions

1. Gradient sensing assay – Fibroblasts or Schwann cells isolated from young (3 mo) and aged (24 mo) mice will be exposed to a microfluidic Shh gradient (2‑3‑fold across 200 µm). Young cells will show a smooth nuclear GLI2‑activator:GLI3‑repressor ratio matching the extracellular slope; aged cells will exhibit a uniform high GLI3‑repressor/low GLI2‑activator ratio regardless of position.
2. ROS‑HDAC link – Treating aged cells with a mitochondria‑targeted antioxidant (MitoQ) or an HDAC inhibitor (SAHA) will restore the proportional GLI activator/repressor gradient without altering total Shh‑induced transcriptional output.
3. In vivo patterning – In aged mice with a Shh‑responsive reporter (Gli1‑LacZ) implanted with a Shh‑releasing hydrogel, young hosts will generate a concentric LacZ intensity pattern, whereas aged hosts will display a binary on/off pattern limited to the hydrogel periphery.
4. Functional correlate – Rescue of nerve repair phenotypes by Shh agonists in aged Schwann cells will persist after HDAC inhibition, but the spatial organization of remyelinated axons (measured by g‑ratio distribution) will improve only when gradient precision is restored.

Experimental Approach

• Cellular: Primary mouse Schwann cells and dermal fibroblasts cultured under defined ROS levels; live‑cell imaging of GLI2‑GFP and GLI3‑mCherry fusions; quantification of nuclear ratios across microfluidic gradients.
• Biochemical: Co‑immunoprecipitation of GLI3 with HDAC1/2, ChIP‑qPCR for H3K27ac at Gli1 enhancer, ROS quantification (MitoSOX).
• In vivo: Implantation of Shh‑secreting alginate beads into young vs. aged murine sciatic nerve; assessment of Gli1‑LacZ pattern and axon myelination.
• Pharmacologic: MitoQ (500 nM) or SAHA (1 µM) administered during gradient exposure.

Falsifiability

If aged cells exhibit a proportional GLI activator/repressor gradient comparable to young cells under identical Shh concentrations, or if antioxidant/HDAC inhibition fails to restore gradient shape without affecting overall pathway activation, the hypothesis would be refuted. Conversely, demonstration that ROS‑dependent HDAC activity directly compresses the GLI activity range would support the claim that aging converts analog Shh signaling into a bistable switch, explaining why functional rescue occurs without architectural regeneration.